Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Breast Cancer Metastatic × Cyclophosphamide × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 280 Lymphoma 256 Leukemia 206 Precursor Cell Lymphoblastic Leukemia-Lymphoma 187 Lymphoma, Non-Hodgkin 161 Multiple Myeloma 156 Leukemia, Lymphocytic, Chronic, B-Cell 156 Lymphoma, Large B-Cell, Diffuse 155 Lymphoma, Follicular 127 Leukemia, Myeloid, Acute 121 Hodgkin Disease 115 Lymphoma, Mantle-Cell 112 Burkitt Lymphoma 107 Myelodysplastic Syndromes 100 Lymphoma, Large-Cell, Immunoblastic 81 Lymphoma, B-Cell, Marginal Zone 75 Recurrence 60 Neoplasms, Plasma Cell 57 Leukemia, Myeloid, Chronic-Phase 54 Dendritic Cell Sarcoma, Interdigitating 53 Leukemia, Myeloid, Accelerated Phase 52 Melanoma 50 Myeloproliferative Disorders 47 Neuroblastoma 45 Blast Crisis 45 Neoplasms 43 Leukemia, Myelomonocytic, Chronic 41 Congenital Abnormalities 39 Lymphoma, Large-Cell, Anaplastic 37 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 37

Interventions

Letrozole 3 exemestane 2 Fulvestrant 2 Anastrozole 2 ribociclib 1 irinotecan sucrosofate 1 abemaciclib 1 Trastuzumab 1 Paclitaxel 1 Liposomes 1 Irinotecan 1 Everolimus 1 Docetaxel 1 Cyclophosphamide 1 Cell Separation 1 Capecitabine 1 Aromatase Inhibitors 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04350021 2024-01-17

METRO

Vastra Gotaland Region

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡